Comparison Study of the ICONâ„¢ Auto Series With and Without SensAwakeâ„¢ and ThermoSmartâ„¢ and Conventional Continuous Positive Airway Pressure in Obstructive Sleep Apnea Patients

NCT ID: NCT01517763

Last Updated: 2019-06-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A total of 216 patients will be randomized into a partially single blind, randomized, parallel-arm trial to determine whether the ICONâ„¢ AT with SensAwakeâ„¢ and ThermoSmartâ„¢ can improve therapy adherence when compared to standard care with a fixed pressure Continuous Positive Airway Pressure (CPAP) device and compared to a less aesthetically pleasing CPAP device without technologies (AutoCPAP, SensAwakeâ„¢, ThermoSmartâ„¢) in patients previously diagnosed with moderate-severe obstructive sleep apnea (OSA).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Apnea, Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional CPAP

Fisher \& Paykel HC244â„¢

Group Type PLACEBO_COMPARATOR

Conventional CPAP Therapy

Intervention Type DEVICE

HC244 devices without Thermosmart or SensAwake

CPAP without Humidification

Fixed pressure ICONâ„¢ without ThermoSmartâ„¢

Group Type ACTIVE_COMPARATOR

Fixed pressure ICONâ„¢ without ThermoSmartâ„¢

Intervention Type DEVICE

Fixed pressure CPAP therapy using ICONâ„¢ without ThermoSmartâ„¢ or SensAwakeâ„¢

APAP with all technologies

Auto ICONâ„¢ with SensAwakeâ„¢ and ThermoSmartâ„¢

Group Type EXPERIMENTAL

Auto ICONâ„¢ with SensAwakeâ„¢ and ThermoSmartâ„¢

Intervention Type DEVICE

APAP therapy using Auto ICONâ„¢ with SensAwakeâ„¢ and ThermoSmartâ„¢

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Conventional CPAP Therapy

HC244 devices without Thermosmart or SensAwake

Intervention Type DEVICE

Fixed pressure ICONâ„¢ without ThermoSmartâ„¢

Fixed pressure CPAP therapy using ICONâ„¢ without ThermoSmartâ„¢ or SensAwakeâ„¢

Intervention Type DEVICE

Auto ICONâ„¢ with SensAwakeâ„¢ and ThermoSmartâ„¢

APAP therapy using Auto ICONâ„¢ with SensAwakeâ„¢ and ThermoSmartâ„¢

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18-70 years with moderate-to-severe OSA (Apnea Hypopnea Index equal to or greater than 10 per hour).
* Successful titration Polysomnography (PSG).
* Fluency in both written and spoken English.

Exclusion Criteria

* Participants prescribed and fitted with any PAP device in the past 2 years.
* Contraindicated for CPAP or AutoCPAP therapy.
* Any known factor or disease that might interfere with treatment adherence, study conduct or interpretation of the results such as severe psychiatric disease, history of non adherence to medical regimens, or unwillingness to comply with study requirements as determined by the principal investigator.
* Other significant sleep disorder(s) that would interfere with their ability to wear CPAP as determined by the principal investigator.
* Previous surgery for OSA or snoring or any surgery of the mouth, nose, sinuses or airways.
* If SensAwakeâ„¢ or ThermoSmartâ„¢ was disabled on the treatment arm (or conversely) during the study protocol.
* If participants are required, by the nature of their employment, to comply with therapy. For example truck drivers or airline pilots.
* If the physician objects to their patient taking part in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sleep Health Centers

OTHER

Sponsor Role collaborator

Fisher and Paykel Healthcare

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sleep HealthCenters

Brighton, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FPH-SA09-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

STIMIT Activator 1 IDE Study
NCT05883163 RECRUITING NA